Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1994-03-21
1995-10-10
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514912, A61K 31275
Patent
active
054571260
ABSTRACT:
Disclosed are methods of using certain defined phenylene dioxamic acids in treating allergic ocular responses, such as, hayfever, conjunctivitis, atopic and keratoconjunctivitis, vernal conjunctivitis, giant capillary conjunctivitis and other diseases where mast cell degranulation are important in the etiology, by topical administration of said active to the affected eye; also disclosed are pharmaceutical compositions comprising said actives.
REFERENCES:
patent: 3993679 (1976-11-01), Hall et al.
patent: 4067995 (1978-01-01), Wright et al.
patent: 4089973 (1978-05-01), Hall et al.
patent: 4169153 (1979-09-01), Wright
patent: 4252813 (1981-02-01), Wright
patent: 4524063 (1985-06-01), Wheeler
Aoki, et al., "Topical Anti-Allergic Activity of Lodoxamide Against a Passive Anaphylaxis Reaction in the Rat Conjunctiva", Investigative Ophthamology and Visual Science, vol. 26, No. 1 (1985).
Watt, et al., "Protective Effect of Lodoxamide Tromethamine on Allergen Inhalation Challenge", Journal of Allergy Clinical Immunology, vol. 66, No. 4, pp. 286-294 (Oct. 1980).
Church, Martin K., "Is inhibition of mast cell mediator release relevant to the clinical activity of anit-allergic drugs?", Agents and Actions, vol. 18, No. 3/4, pp. 288-293 (1986).
Aoki K. Roger
DeSantis Louis M.
Alcon Laboratories Inc.
Arno James A.
Brown Gregg C.
Fay Zohreh
LandOfFree
Use of lodoxamide to treat ophthalmic allergic conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of lodoxamide to treat ophthalmic allergic conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of lodoxamide to treat ophthalmic allergic conditions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2310678